Ariste Medical LLC
Drug-eluting mesh for open ventral hernia repair
This article was originally published in Start Up
Executive Summary
Ventral hernia repair is associated with a relatively high incidence of microbial contamination of the surgical site, ranging from 8% to 40%. To combat infection, Ariste Medical LLC has developed a mid-weight hernia mesh that features a proprietary polymer coating embedded with a programmed release of two proven antimicrobials.